Zurueck zur Suche

Reporte zur Charge U038662

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 2 TX 2 FL 1 NC 1 MN 1 VA 1 PA 1

VAERS 2548941

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u038662

schwer
Staat
FL
Alter
14,0
Geschlecht
M
Eingang
03.01.2023
Impfdatum
13.12.2022
Beginn
15.12.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Brain oedema Seizure

Symptomtext

2 days after receiving TdaP, MCV4, and HPV9 patient had a new onset seizure. Found to have swelling of the brain per mother in hospital. Now taking prednisone and valproic acid.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Hospitalized. Medical records are pending and have not been recieved yet
Aktuelle Erkrankungen
None
Vorgeschichte
Depression
Andere Medikamente
lorazepam and olanzapine
Allergien
None
Vorherige Impfungen
-

VAERS 2546894

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u038662

schwer
Staat
NC
Alter
17,0
Geschlecht
F
Eingang
30.12.2022
Impfdatum
30.12.2022
Beginn
30.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness

Symptomtext

Patient passed out/blacked out

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Check vitals after patient passed out all were normal
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2515275

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U038662

schwer
Staat
MN
Alter
17,0
Geschlecht
F
Eingang
23.11.2022
Impfdatum
23.11.2022
Beginn
23.11.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Pallor Syncope

Symptomtext

Approx 1015 am, immediately following 4th vaccine injection (mening) pt. became pale, swayed to the side and fainted. Nurse lowered her to the lfoor slowly, put legs up, by the time she was on the floor, she was awake. She had not eaten breakfast prior to appointment and stated later she has fainted before with vaccination (x1). This was not shared with nurse. Felt completely fine after juice and a snack (15 minutes).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
information regarding previous fainting unknown

VAERS 2489803

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U038662

schwer
Staat
NY
Alter
12,0
Geschlecht
M
Eingang
17.11.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electrocardiogram Syncope

Symptomtext

Syncope; This spontaneous case was retrieved on 10-Nov-2022 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2489803-1), reported by other healthcare professional and concerned a 12-year-old, male patient. The patient's medical history and concomitant medications were not reported. It was reported that on 24-Oct-2022, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: reported as 'one', route of administration: intramuscular (IM), anatomical location: right arm (RA), indication: not reported). The batch number reported was 348362. The reported batch number was identified by Seqirus to be linked to suspect product Flucelvax Quadrivalent (influenza vaccine inact sag 4v) instead of reported suspect product Fluad Quadrivalent. Based on the reported batch number, the suspect product was changed to Flucelvax Quadrivalent. On the same date, the patient was vaccinated with non-company co-suspect Gardasil 9 (hpv vaccine vlp rl1 9v (yeast); dose: reported as 'two', route of administration: intramuscular (IM), anatomical location: left arm (LA), indication: not reported). The batch number reported was U038662. On the same date, five and a half hours after receiving Flucelvax Quadrivalent and co-suspect Gardasil 9, the patient experienced syncope. On 25-Oct-2022, the patient had an ordered electrocardiogram (EKG), however, the results were not provided. At the time of initial reporting, the patient had not recovered from the event of syncope. The reporter did not provide a causality assessment. The event of syncope was considered to be medically significant by a Physician within Seqirus's Pharmacovigilance and Risk Management Department. Company comment: A 12-year-old, male patient was vaccinated with the Flucelvax Quadrivalent and non-company co-suspect Gardasil 9 vaccine. Five and a half hours after vaccination, the patient experienced syncope. The patient had an ordered electrocardiogram (EKG), however, the results were not provided. The patient's medical history and concomitant medications were not reported. Causality was confounded by concurrent administration of co-suspect vaccine. Causal role of the suspect vaccine is assessed as possibly related, with the currently available information and plausible temporal relationship.; Sender's Comments: A 12-year-old, male patient was vaccinated with the Flucelvax Quadrivalent and non-company co-suspect Gardasil 9 vaccine. Five and a half hours after vaccination, the patient experienced syncope. The patient had an ordered electrocardiogram (EKG), however, the results were not provided. The patient's medical history and concomitant medications were not reported. Causality was confounded by concurrent administration of co-suspect vaccine. Causal role of the suspect vaccine is assessed as possibly related, with the currently available information and plausible temporal relationship.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2489803

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U038662

schwer
Staat
NY
Alter
12,0
Geschlecht
M
Eingang
17.11.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electrocardiogram Syncope

Symptomtext

Syncope; This spontaneous case was retrieved on 10-Nov-2022 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2489803-1), reported by other healthcare professional and concerned a 12-year-old, male patient. The patient's medical history and concomitant medications were not reported. It was reported that on 24-Oct-2022, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: reported as 'one', route of administration: intramuscular (IM), anatomical location: right arm (RA), indication: not reported). The batch number reported was 348362. The reported batch number was identified by Seqirus to be linked to suspect product Flucelvax Quadrivalent (influenza vaccine inact sag 4v) instead of reported suspect product Fluad Quadrivalent. Based on the reported batch number, the suspect product was changed to Flucelvax Quadrivalent. On the same date, the patient was vaccinated with non-company co-suspect Gardasil 9 (hpv vaccine vlp rl1 9v (yeast); dose: reported as 'two', route of administration: intramuscular (IM), anatomical location: left arm (LA), indication: not reported). The batch number reported was U038662. On the same date, five and a half hours after receiving Flucelvax Quadrivalent and co-suspect Gardasil 9, the patient experienced syncope. On 25-Oct-2022, the patient had an ordered electrocardiogram (EKG), however, the results were not provided. At the time of initial reporting, the patient had not recovered from the event of syncope. The reporter did not provide a causality assessment. The event of syncope was considered to be medically significant by a Physician within Seqirus's Pharmacovigilance and Risk Management Department. Company comment: A 12-year-old, male patient was vaccinated with the Flucelvax Quadrivalent and non-company co-suspect Gardasil 9 vaccine. Five and a half hours after vaccination, the patient experienced syncope. The patient had an ordered electrocardiogram (EKG), however, the results were not provided. The patient's medical history and concomitant medications were not reported. Causality was confounded by concurrent administration of co-suspect vaccine. Causal role of the suspect vaccine is assessed as possibly related, with the currently available information and plausible temporal relationship.; Sender's Comments: A 12-year-old, male patient was vaccinated with the Flucelvax Quadrivalent and non-company co-suspect Gardasil 9 vaccine. Five and a half hours after vaccination, the patient experienced syncope. The patient had an ordered electrocardiogram (EKG), however, the results were not provided. The patient's medical history and concomitant medications were not reported. Causality was confounded by concurrent administration of co-suspect vaccine. Causal role of the suspect vaccine is assessed as possibly related, with the currently available information and plausible temporal relationship.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2685605

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U038662

mild
Staat
TX
Alter
38,0
Geschlecht
F
Eingang
24.09.2023
Impfdatum
03.03.2023
Beginn
01.03.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Joint range of motion decreased Pain

Symptomtext

Soreness in right shoulder did not dissipate, has since become painful to move and lift or reach for items. Also range of motion has been significantly impaired. Attended physical therapy sessions with little to no improvement. Referral has been made to an orthopedic doctor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
None at this time
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension, obesity, depression, anxiety
Andere Medikamente
Omeprazole 20mg, Triamterene/HCTZ 37.5/25mg, Meloxicam 15mg, Cetirizine 10mg, Bupropion XL 450mg, Norethindrone 5mg, Montelukast 10mg, Fluvoxamine 200mg, Trazodone 100mg, Ropinirole 0.5mg, Advil 400-600mg, Tylenol 500mg
Allergien
None known
Vorherige Impfungen
-

VAERS 2655985

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U038662

mild
Staat
-
Alter
21,0
Geschlecht
M
Eingang
13.07.2023
Impfdatum
11.07.2023
Beginn
12.07.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Diarrhoea Extrasystoles Pyrexia

Symptomtext

Reports sensation of heart skipping beat since last night at 11pm into 11am this morning. Also with fever of 100-101. Took advil and tylenol with relief. No further cardiac symptoms since this AM (now 4pm). Also with diarrhea, however thinks this was triggered by spicy food he had. Feeling improved now, no other symptoms. Had HPV vaccine 2 days ago (1 day prior to symptom onset).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
hypogonadism in male irritable bowel syndrome
Andere Medikamente
pepcid truvada testosterone
Allergien
cephalosporins bacitracin-polymixin penicillins
Vorherige Impfungen
-

VAERS 2624259

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U038662

gering
Staat
TX
Alter
18,0
Geschlecht
F
Eingang
01.05.2023
Impfdatum
28.04.2023
Beginn
28.04.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Meningococcal was given/administered as a third dose. Vaccine was administered, 04/28/2023, extra as third dose when she had already received her second dose and was fully vaccinated for her age.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
No testing required and or needed. Patient admitted to no reaction and or symptoms.
Aktuelle Erkrankungen
No.
Vorgeschichte
None.
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2577373

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U038662

gering
Staat
VA
Alter
18,0
Geschlecht
F
Eingang
07.02.2023
Impfdatum
04.11.2022
Beginn
04.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Product administration error

Symptomtext

Administration error: MMR given on 11/3/2022 and Varicella given on 11/4/2022 at the same facility. Time and spacing between 2 lives vaccines invalidated the varicella given on 11/4/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2522216

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U038662

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
02.12.2022
Impfdatum
28.11.2022
Beginn
28.11.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

No additional AE.; Caller stated a patient who received the complete series previously was administered a fourth dose.; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On unknown dates, the patient was vaccinated with first, second and third doses of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (doses, routes of administration, anatomical locations, lot numbers and expiration dates were not reported) for prophylaxis. On 28-NOV-2022, the patient was vaccinated with a fourth dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe, dose of 0.5 mL, lot number: U038662, expiration date: 10-AUG-2024 (route of administration and anatomical location were not reported) for prophylaxis (extra dose administered). No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-